Events

2024

Departmental Seminar

Date: 1:00PM, Thursday, 25 April 2024

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

A Seminar 

by

Dr ZHANG Qingyang
Post-doctoral Fellow 
Department of Pathology 
School of Clinical Medicine 
The University of Hong Kong 

and
 
The Translation Value of BQ323636.1, 
a splice variant of NCOR2, in the Management of ER-positive Breast Cancer 

by 

Dr TSOI Ho, Frankie 
Research Assistant Professor 
Department of Pathology 
School of Clinical Medicine 
The University of Hong Kong 

Departmental Seminar

Date: 1:00PM, Tuesday, 2 April 2024

Venue:
Lecture Theatre, 2/F, Block T, Queen Mary Hospital

A Seminar

Artificial Intelligence in Pathology: 
from Diagnostic to Advanced Applications

by

Dr. Yuri Tolkach
Institute of Pathology
University Hospital Cologne
Germany

All are welcome

Departmental Seminar

Date: 1:00PM, Thursday, 28 March 2024

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

A Seminar

Metabolic reprogramming of pentose phosphate pathway mediated by
small extracellular vesicles facilitates tumor metastasis and drug resistance in hepatocellular carcinoma

by

Dr ZHANG Xiaoxin, Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

and

Optimization of the library to enhance DIA proteomics for the identification of HCC biomarkers

by

Professor MA Hoi Tang, Ken, Assistant Professor
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

All are welcome

11th Hong Kong Pathology Forum

Date: 3 February 2024 (Saturday)

Venue:

Concord Room, Level 8, Renaissance Harbour View Hotel Hong Kong

Click here for details


2023

Departmental Seminar

Date: 12:30PM, Thursday, 14 December 2023

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

 

A Seminar

Exploring the heterogeneity of hypoxia response and investigating the role of synonymous mutations
in hepatocellular carcinoma: a multi-omics analysis

by

Mr Wang Gengchao
PhD student
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

and

Clathrin light chain A-enriched small extracellular vesicles remodel microvascular niche
to induce hepatocellular carcinoma metastasis

by

Dr Xu Yi
Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

All are welcome

Symposium 2023 of State Key Laboratory of Liver Research (HKU) and RGC Theme-based Research Project

Date: 25 November 2023 (Saturday), 9AM – 5PM

Venue:

JW Marriott Hotel Hong Kong, 88 Queensway, Admiralty, Hong Kong & Via Zoom

For details: 

https://skllr.med.hku.hk/en/News-And-Events/Events

Departmental Seminar

Date: 1:00PM, Thursday, 23 November 2023

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

 

A Seminar

Deciphering the impacts of collagen type I and interleukin-6 in diffuse-type gastric cancer progression
using CDH1-deficient human gastric organoid models

by

Miss Choy Hiu Ching

MPhil student
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

and

Modelling diffuse-type gastric cancer in human organoids by CRISPR/Cas9

by

Dr Choi Jeeeun
Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

All are welcome

A Seminar by Professor Xin Lu, Ludwig Institute for Cancer Research, University of Oxford, United Kingdom

Date: 2:00PM, Tuesday, 31 October 2023

Venue:

Lecture Theatre, 2/F, Block T, Queen Mary Hospital

 

A Seminar

Infection, Cell Plasticity and Upper GI Cancers

by

Professor Xin Lu

Ludwig Institute for Cancer Research
Nuffield Department of Medicine
University of Oxford, UK

Professor Xin Lu is the Director of the Ludwig Institute for Cancer Research and Professor of Cancer Biology at the University of Oxford, UK.  She is a leading cancer cell biologist with long-standing research interests in tumour suppression.  She was one of the first researchers to show that the tumour suppressor p53 responds to both oncogene activation and DNA damaging signals and her group was also among the first to demonstrate how to selectively activate p53 to kill cancer cells, through identification and characterization of the evolutionarily conserved ASPP family of proteins. Her laboratory has broad interests in the molecular mechanisms that control cellular plasticity, including how external signals - such as infection - are integrated into the nucleus to achieve target-selective transcription and cell fate determination. 

Professor Lu has been elected as a Fellow of the Royal Society 2020, the UK’s distinguished academy of science, for her contributions to cancer biology. Xin is also a Member of the Academy of Medical Sciences, a Member by election of the Academia Europaea, and a Member of the European Molecular Biology Organisation. Xin is Co-Director of the Cancer Research UK Oxford Centre, Cancer Theme Leader for the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and Director of the Oxford Centre for Early Cancer Detection. She has a BSc from Sichuan University, MSc from Peking Union Medical College, Chinese Academy of Medical Sciences in China, PhD from University College London (UCL) and the former Imperial Cancer Research Fund, and postdoctoral training at Dundee University, UK. She was appointed as the Director of Ludwig Institute in London at UCL in 2004 and she established Ludwig Oxford as Director in 2007.

All are welcome

Departmental Seminar

Date: 1:00PM, Thursday, 26 October 2023

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

 

A Seminar

Long-read sequencing uncovers alternative transcript isoforms essential for hypoxic adaptation in hepatocellular carcinoma

by

Miss WAN Ting Chi Rebecca

PhD student
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

and

The Role of Small Extracellular Vesicle-derived Nicotinamide Phosphoribosyltransferase (NAMPT) in the Progression of Hepatocellular Carcinoma

by

Dr NG Tung Him Tony
Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

All are welcome

Seminars by Miss SIT Fu Wan and Dr CHEN Ao

Date: 1:00PM, Thursday, 31 August 2023

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

 

A Seminar

Immunophenotyping of anti-PD-L1 treated hepatocellular carcinoma (HCC)

by

Miss SIT Fu Wan
MPhil student
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

and

Targeting oncogenic m6A demethylase FTO suppresses tumorigenesis and potentiates immunotherapy efficacy in hepatocellular carcinoma

by

Dr CHEN Ao
Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

All are welcome

Research Postgraduate Seminar

Date: 1:00PM, Thursday, 27 July 2023

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

 

A Seminar

Sensitive and Accurate Viral Integration Detection in HBV-associated Hepatocellular Carcinoma

by

Miss Lyu Xueying
PhD student
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

Synopsis:

Hepatitis B virus (HBV) infection is one of the key etiological risk factors for HCC. Sensitive and accurate detection of HBV integration is crucial to the investigation of the molecular pathogenesis of HCC. We developed the software AVID for HBV integration detection with the enhanced algorithm. AVID outperformed other existing tools in terms of precision, F1 score, and recall in simulated datasets and experimentally validated datasets. Notably, regarding the landscape of HBV integration in HCC, we were able to sensitively and accurately identify recurrent HBV integration events related to TERT, KMT2B, and CCNE1.

and

Anti-Stanniocalcin 1 Antibody as a Potential Therapeutic Strategy for Liver Fibrosis and Hepatocellular Carcinoma

by

Mr Suen Long Hin
MPhil student
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

Synopsis:

Liver fibrosis is part of the multi-step hepatocarcinogenesis process and persists after the development of hepatocellular carcinoma (HCC). Stanniocalcin 1 (STC1) is a serum biomarker in liver fibrosis and HCC, which is functionally involved in both diseases. In this study, the preclinical efficacy of anti-STC1 antibody in mitigating both metastatic potential of HCC cells and activation of hepatic stellate cells (HSCs) was evaluated. The functional role of anti-STC1 antibody in the interplay between HSCs and HCC cells was also studied. The downstream molecular mechanisms mediated by anti-STC1 antibody in the liver fibrosis cell line model was elucidated by proteomic profiling.

All are welcome

Seminars by Dr CHAN Yuen Ki and Dr TIAN Lu

Date: 1:00PM, Thursday, 27 April 2023

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

 

A Seminar

STING agonist as novel and effective therapy in anti-PD-1 resistant liver cancers

by

Dr CHAN Yuen Ki
Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

and

RalA enhances metastasis in hepatocellular carcinoma via upregulating exosomal fibronectin

by

Dr TIAN Lu
Post-doctoral Fellow
Department of Pathology
School of Clinical Medicine
The University of Hong Kong

All are welcome

10th Hong Kong Pathology Forum

Date: 4 February 2023 (Saturday)

Venue:
Prof Tak Mak Prof Leo LM Poon Dr Carmen Cl Wong Dr Carmen Cl Wong Prof Tak Mak

Island-Shangri-La Hotel, Hong Kong (Atrium, Level 39) & via Zoom

Symposium I: Paediatric Pathology

Hou Pao-Chang Medical Memorial Fund Lecture
Professor Miguel Reyes-Múgica (Department of Pathology, University of Pittsburgh School of Medicine, USA)
Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era

Professor Godfrey Chi-Fung Chan (Department of Paediatrics & Adolescent Medicine, HKU)
Clinical Impact of Pathology Report on Management of Paediatric Diseases

Dr Rex Kwok-Him Au-Yeung (Department of Pathology, HKU)
Mature B-cell Lymphomas in Children and Adolescents

Symposium II: Dermatopathology

James Gibson Lecture
Professor May Puiyan Chan (Departments of Pathology and Dermatology, University of Michigan, USA)
Connective Tissue Diseases in the Skin: Emerging Concepts and Updates on Molecular and Immune Drivers of Disease

Dr Kam-Cheong Lee (Department of Pathology, Princess Margaret Hospital)
Dermatopathology: Beyond Gestalt Diagnosis

Dr King-Chung Lee (Pathology Department, St. Paul’s Hospital)
Cutaneous Vasculitis – Common Pitfalls in Histological Evaluation

Professor Henry Hin-Lee Chan (Department of Medicine, HKU)
Pigmented Lesion to Treat or Not to Treat

Symposium III: Chemical Pathology

Dr Yat-Fung Shea (Department of Medicine, Queen Mary Hospital)
An Update on Clinical Usage of Biomarkers of Alzheimer’s Disease

Dr Henry Ka-Fung Mak (Department of Diagnostic Radiology, HKU)
Neuroimaging of Dementia

Dr Eric Chun-Yiu Law (Department of Pathology, Hong Kong Children's Hospital)
Biochemical and Genetic Diagnosis of Alzheimer’s Disease

State-of-the-Art Lecture

Professor Miguel Reyes-Múgica (Department of Pathology, University of Pittsburgh School of Medicine, USA)
Updates on Pathology of Testicular Tumours in Children

Professor May Puiyan Chan (Departments of Pathology and Dermatology, University of Michigan, USA)
Update on Classification and Molecular Pathology of Cutaneous Adnexal Neoplasms

Click here for more information, and here for event photos


2022

Symposium 2022 of State Key Laboratory of Liver Research (HKU)

Date: 9:00 am to 5:00 pm, October 29, 2022 (Saturday)

Venue:

Hybrid – JW Marriott Hotel Hong Kong (88 Queensway, Admiralty) & Zoom

Event website click here


Research Postgraduate Seminar: 7 July 2022

Date: 1:00 PM, Thursday, 7 July 2022

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

Precision mouse model guides precision medicine in hepatocellular carcinoma - the genetic landscape determines the immune landscape and response to immune checkpoint inhibitors
by
Mr. Yuen Wai Hin Vincent, PhD student
(Supervisor: Dr. Carmen Wong)

Synopsis:

"Hepatocellular carcinoma is highly lethal due to limited treatment options. To date, tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) are the only two classes of FDA-approved drugs for advanced HCC patients. TKIs have long clinical history in HCC treatment with modest survival benefits. ICIs have remarkable outcome but only limited to a minority of HCC patients. Understanding the mechanisms that determine the efficacy of ICIs in HCC is beneficial to the stratification of patients who will likely respond to ICIs. The primary focus of this study is to elucidate how genetic composition orchestrates the immune composition of HCC. To robustly study how genetic alterations shape HCC tumor immune microenvironment (TIME) thereby affecting the response to ICI, we generated a library of mouse HCCs with genotypes that closely simulate the genetic composition found in human HCCs using genome-editing systems involving transposon and CRISPR-Cas9 systems by hydrodynamic tail-vein injection (HDTVi). Based on the CD8+ T cell infiltration level, we characterized different HCC genotypes into cold tumors (low number of CD8+ T cell) and hot tumors (high number of CD8+ T cell). Anti-PD-1 treatment had no effect in cold tumors but was greatly effective in hot tumors. RNA sequencing of HCC tissues and single-cell RNA sequencing analysis of tumor-infiltrating T cells identified the responsible proinflammatory cytokines and chemokines for CD8+ T cell infiltration in hot tumors. We further characterized different subsets of exhausted T cells in hot and cold tumors and identified a new exhausted T cell population which might potentially serve as a predictive indicator to anti-PD-1 treatment. Interestingly, we found that the TKI, Sorafenib, sensitized cold tumors to anti-PD-1 treatment. In sum, our study has exemplified the use of genome-editing systems to generate mouse HCCs to precisely simulate the same genetic makeup of human HCC to pave the way for precision medicine."

All are welcome

Research Postgraduate Seminar: 30 June 2022

Date: 1:00 PM, Thursday,30 June 2022

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital (Face-to-face format)

LANCL1-FAM49B axis promotes cancer stemness of hepatocellular carcinoma by reducing NADPH oxidase-mediated oxidative stress
by
Mr. Hongyang Huang, PhD student
(Supervisor: Professor Irene Ng and Dr. Yu-Man Tsui) 

Synopsis:

"Cancers including hepatocellular carcinoma (HCC) contain a subpopulation of highly tumorigenic tumor-initiating cells (TICs). Targeting TICs is strategic for cancer treatment. Here, we identify a novel TIC marker of HCC, LANCL1, and its upregulation promotes TIC properties including sphere formation, chemoresistance, and tumor initiation. Our mechanistic study indicates that LANCL1-mediated cancer stemness is via suppression of ROS. LANCL1 blocks the interaction of FAM49B with an E3 ligase, TRIM21, thus protecting FAM49B from ubiquitination and degradation. Enrichment of FAM49B inhibits RAC1 activation, which in turn reduces NADPH oxidase (NOX)-mediated ROS production. Targeting the LANCL1-FAM49B axis may be a potential strategy for HCC treatment."

All are welcome

Research Postgraduate Seminar: 23 June 2022

Date: 1:00 PM, Thursday, 23 June 2022

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital (Face-to-face format)

Ferroptosis suppressor protein 1 (FSP1) inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer
by
Miss Cheu Wing Sum Jacinth, PhD student
(Supervisor: Dr Carmen Wong)

Synopsis:

"Ferroptosis is a form of immunogenic cell death characterized by iron-dependent lipid peroxidation. FSP1 is one of the major pathways protect cells against ferroptosis, that is recently discovered. Excitingly, we found that HCC cells relied on FSP1 to protect them against ferroptosis and the induction of ferroptosis by FSP1 inhibitor (iFSP1) suppressed HCC growth. More importantly, iFSP1 altered immune landscape of HCC tumor and promoted tumor infiltration of DCs, macrophages and T cells. iFSP1 also worked synergistically with multiple immunotherapies. In sum, ferroptosis induction promotes innate and adaptive anti-tumor immune responses and is a promising therapeutic approach in treating HCC."

All are welcome

Research Postgraduate Seminar: 21 Apr 2022

Date: 1:00 PM, Thursday, 21 April 2022

Venue:

Delivered via Zoom Meeting ID: 990 1600 3989

Impact and mechanisms of ferroptosis in ovarian carcinoma

by
Mr Li Jing, PhD student
(Supervisor: Professor CHEUNG NY Annie) 

"Ovarian carcinoma (OC) is a malignancy with grave prognosis owing to frequent resistance to apoptosis-inducing platinum-based chemotherapy. Ferroptosis is a recently defined non-apoptotic cell death driven by the accumulation of iron-dependent lipid reactive oxygen species (ROS), resulting in membrane oxidative damage and cell rupture. Lines of evidence suggested that OC may be susceptible to ferroptosis. However, the effects mediated by ferroptosis and the underlying regulatory mechanisms in OC are not fully characterized. Herein, we demonstrated the general susceptibility of OC cells to ferroptosis and the critical role of ferroptosis in enhancing the cytotoxicity of cisplatin in cisplatin-resistant OC. Additionally, we suggested that EPT1 exerted as a potential ferroptosis suppressor gene by modulating autophagy, providing new insights into the molecular mechanisms of ferroptosis in OC."

All are welcome

Remark:
21.4.2022 QR Code.jpg 

Meeting ID: 990 1600 3989

A Seminar: Combined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer

Date: 1:00 PM-2:00PM, postponed to 17 March 2022 (Thursday)

Venue:

Delivered via Zoom Meeting ID: 990 9276 2563

Combined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer
By
Dr Leung Man Hong
Post-doctoral Fellow
Department of Pathology School of Clinical Medicine
The University of Hong Kong

All are welcome

MLT CPD code: 04221011
CME:1 point (HKCPath)

Remark:
Qr code 24.2.2022

HK Pathology Forum 2022

Date: 19 Febuary 2022 (Sat)

Venue:
Prof Tak Mak Prof Leo LM Poon Dr Carmen Cl Wong Dr Carmen Cl Wong Prof Tak Mak

Via by Zoom

Topic:

Professor Ralph HRUBAN (USA)

A ‘Clearer’ Three-dimensional View of Pancreatic Cancer

Dr Tan-To CHEUNG (HK)

Update in Management of Pancreatic Cancer

Dr Elizabeth THOMPSON (USA)

The Pathology of Precursor Lesions of the Pancreas

Professor Ming-Sound TSAO (Canada)

Twenty Years Progress and Future of Lung Cancer Pathology

Dr Elaine Yuen-Ling AU (HK)

Drug Allergy Laboratory Assays

Dr Philip Hei LI (HK)

Drug Allergy Testing: From Bench to Bedside

Dr Eric Chun-Yiu LAW (HK)

Therapeutic Drug Monitoring and Pharmacogenomics of Cytotoxic Drugs

Dr Chloe Miu MAK (HK)

Next Generation Sequencing for Second Tier Testing in Newborn Screening for Inborn Errors of Metabolism

Dr Albert Chun-Fung SIN (HK)

The Way Forward to Improve the Outcome of Acute Lymphoblastic Leukaemia

Dr Rock Yuk-Yan LEUNG (HK)

Strategic Monitoring of Measurable Residual Disease (MRD) for Acute Lymphoblastic Leukaemia

Professor Ming-Sound TSAO (Canada)

Early-stage Lung Cancers – Challenges and Opportunities

Professor Tony Shu-Kam MOK (HK)

A Genomic Revolution in Management of Lung Cancer

 Click *Here to download Forum Programme Book 2022 (*pdf format around 8mb)

Click Here for more information.


2021

Research Postgraduate Seminar: 2 Dec 2021

Date: 1:00 PM-2:00PM, Thursday, 2 Dec 2021

Venue:

1:00PM-2:00PM, Thursday, 2 December 2021, Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar:

Targeting CHK2 to Reverse the Tamoxifen
Resistance by Reducing BQ323636.1 in Estrogen
Receptor Positive Breast Cancer

by
Mr Tsang Wai Chung, M. Phil Student

(Supervisor: Professor KHOO UI Soon)

Synopsis:

"BQ323636.1 (BQ) a splice variant of NCOR2, is associated with tamoxifen (TAM) resistance. TAM can cause DNA-damage, triggering the ATM-CHK2 DNA-damage response pathway. We hypothesized this might upregulate BQ-expression, causing TAM resistance. Targeting ATM can cause BQ downregulation, but results in cytotoxicity. Hence targeting CHK2, downstream of ATM, might be a better strategy. Using TAM resistant cell-line LCC2, we confirmed that CHK2-knockdown, or treating cells with CHK2 inhibitor, PV1019, could reduce BQ-expression and sensitize LCC2 to tamoxifen, both in vitro and in vivo. These findings suggest that targeting CHK2 could be a strategy for reducing TAM resistance in breast cancer."

All are welcome

A Seminar: ingle-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBVassociated hepatocellular carcinoma

Date: 1:00 PM-2:00PM, Thursday, 25 Nov2021

Venue:

A Seminar:

Single-cell RNA sequencing shows
the immunosuppressive landscape
and tumor heterogeneity of HBVassociated hepatocellular
carcinoma

by
Dr Ho Wai Hung Daniel
Assistant Professor
Department of Pathology

The University of Hong Kong
25 November 2021 (Thursday)
Time: 1:00 pm
Venue: Delivered via Zoom
Meeting ID: 996 5683 6618

MLT CPD code: 04211041
CME:1 point (HKCPath)

Remark:
SeminarQRCode 25.11.21

A Seminar:Deconstruct a Novel Mutation Signature from Colon Cancer

Date: 1:00 PM-2:00PM, Thursday, 28 Oct2021

Venue:

A Seminar:

Deconstruct a Novel Mutation Signature from Colon Cancer
by
Dr Siu Hoi Cheong Post-doctoral Fellow
Department of Pathology
The University of Hong Kong

Date:   28 October 2021 (Thursday)
Time:  1:00 pm (HKT)
Venue:  Delivered via Zoom
Meeting ID: 917 7273 2577
All are welcome
Registration

MLT CPD code: 04211031
CME:1 point (HKCPath)

Remark:
zoom 28.10.2021

Research Postgraduate Seminar

Date: 1:00PM-2:00PM, Thursday, 30 Sep 2021

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar:

Dysregulation of Ral GTPase-Activating Protein Complex Activates RalA Signaling and Supports Metastasis of Hepatocellular Carcinoma through Intrinsic and Extracellular Vesicle-dependent Manners

by

Ms Tian Lu, PhD student

(Supervisor: Professor Ng Oi Lin Irene)

1:00PM-2:00PM, Thursday, 30 September 2021 Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar

Date: 1:00PM-2:00PM, Thursday, 26 Aug 2021

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar:

The Role of Lumican in Hepatocellular Carcinoma
by

Miss Wong Cheuk Yan, MPhil student
(Supervisor: Dr Lo Cheuk Lam Regina)

Monopolar Spindle 1 (MPS1) Kinase Inhibitor Abrogates the Spindle Assembly Checkpoint and Leads to Insurmountable Genome Instability and Cell Death in Uterine Leiomyosarcoma
by
Mr Wong Ho Shing, MPhil student
(Supervisor: Dr Ip Pun Ching Philip)

1:00PM-2:00PM, Thursday, 26 Aug 2021 Room 035, 6/F, Block T, Queen Mary Hospital

Seminar: Undifferentiated Pleomorphic Sarcoma - a Case Study :Dr Arthur Leung (Conducted via Zoom)

Date: 13:00HKT 19 August 2021 (Thursday) Conducted via Zoom

Venue:

Conducted via Zoom
Meeting ID:   975 1152 1794
Registration
: https://hku.zoom.us/meeting/register/tJModuitrDotE9CFgLJeFk67xwOx5_77ORm-


Meeting ID: 975 1152 1794
MLT CPD code: 04211021

CME:1 point (HKCPath)

Remark:
QR code zoom link  for 19.8.2021 new
QR code for Join

Research Postgraduate Seminar

Date: 1:00PM-2:00PM, Thursday, 29 July 2021

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar:

Decoding the Function of Long Noncoding RNAs in Hepatocellular Carcinoma
by Miss Wong Lok Sze, PhD student
(Supervisor: Wong Chun Ming Jack)

The Role of IL-25 in the Pathogenesis of Sjögren's Syndrome
by Mr Deng Chong, PhD student
(Supervisor: Professor Lu Liwei)

1:00PM-2:00PM, Thursday, 29 July 2021 Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar

Date: 1:00PM-2:00PM, Thursday, 15 July 2021

Venue:

Room 035, 6/F, Block T, Queen Mary Hospital

Research Postgraduate Seminar:

The Role of B Cells in the Development of Sjögren's Syndrome
by Mr Du Wenhan,
PhD student (Supervisor: Professor Lu Liwei)

Arsenic Trioxide-induced Autophagy and its Role in T-cell Acute Lymphoblastic Leukemia
by Miss Qiu Yinxia, MPhil student
(Supervisor: Dr Sin Chun Fung Albert )

1:00PM-2:00PM, Thursday, 15 July 2021 Room 035, 6/F, Block T, Queen Mary Hospital

Seminar: Immunology- the Organ for All Seasons on 3 July, 2021 (Sat)

Date: 3 July 2021

Venue:

G/F, Lecture Theatre 2, William MW Mong Block, 21 Sassoon Road, Pokfulam

Immunology- the Organ for All Seasons

Updated

More about Speaker information:

Professor Tak Wah MAK
Professor Leo Lit-Man POON
Dr Heidi Guang-Sheung LING
Dr Carmen Chak-Lui WONG

For in-person attendance, please register on or before 24 June 2021 (Thursday) via the link below

https://hkuems1.hku.hk/hkuems/ec_hdetail.aspx?ueid=75848

Please bring your registration record to the staff on-site for final confirmation.

For online Zoom attendance, please register via the link below:

https://hku.zoom.us/meeting/register/tJApceuvqDMsGNL4LPLR92ooFjII6ymV4T4V

For enquiries, please contact the Department of Pathology at tel:  2255 2664 / email: lklei@pathology.hku.hk

 

Prof Tak Mak Prof Leo LM Poon Dr Carmen Cl Wong Dr Carmen Cl Wong Prof Tak Mak

Symposium 2021 of State Key Laboratory of Liver Research (HKU) and Theme-Based Research Scheme Project on Liver Cancer Stemness

Date: June 5, 2021 (Saturday)

Venue:

Date: June 5, 2021 (Saturday)
Time: 9:00 am to 5:00 pm
Format: Hybrid
Online – Zoom
Onsite – The Park Lane Hong Kong A Pullman Hotel (310 Gloucester Road, Causeway Bay)

Full detail : http://www.skllr.hku.hk/en/News-And-Events/Events

Free registration ( Click Here)

Seminar: The Role of Proteasome Inhibitors in Acute Lymphoblastic Leukaemia by Dr Sin Chun Fung Albert

Date: 27 May2021 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom (click here)
Meeting ID: 966 5602 4899

MLT CPD code: 04211011
CME:1 point (HKCPath)

Seminar: Exogenous antioxidants, N-acetylcysteine and glutathione, enhance cancer initiation and growth in hepatocellular carcinoma

Date: 25 Mar2021 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom (click here)
Meeting ID: 997 5078 1537

MLT CPD code: 04201091
CME:1 point (HKCPath)

Seminar: Genetics of B-cell lymphomas in childhood

Date: 18 Mar2021 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom (click here)
Meeting ID: 953 7477 1429

Remark:
MLT CPD code: 04201081
CME:1 point (HKCPath)  

Seminar: Organoid Cultures of Early-onset Colorectal Cancers Reveal Distinct and Rare Genetic Profiles by: Dr Helen Yan

Date: 04 Feb 2021 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom
Meeting ID: 920 8466 0074

Remark:
MLT CPD code:04201061
CME:1 point (HKCPath)  

Hong Kong Pathology Forum 2021

Date: 30 January 2021(Saturday) 0900-1605 (UTC+8)

Remark:

Forum Detail
Symposium I: Liver
State-of-the-Art Lectures
Symposium II: Molecular and Genetics & Genomics
Symposium III: Artificial Intelligence and Computational Pathology

Click here for full detail


2020

Seminar: Hypoxia-induced Macropinocytosis Represents a New Metabolic Route for Liver Cancer by Dr Zhang Shuo Misty

Date: 17 Dec 2020 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom
Meeting ID: 969 0009 4929

Remark:
MLT CPD code: 04201051
CME:1 point (HKCPath)  

Seminar: Role of CAMKIIα in Mediating Tumor-initiating Cell Phenotypes in Lung Adenocarcinoma by: Dr Xiao Zhijie Phyllis

Date: 26 Nov 2020 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom
Meeting ID: 940 2328 0499

Remark:
MLT CPD code: 04201031
CME:1 point (HKCPath)  

Seminar: Drug Resistance in Breast Cancer: the Significance of the NCOR2 Splice Variant, BQ323636.1 by: Prof Khoo

Date: 19 Nov 2020 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom

 Meeting ID: 978 8221 0800

Remark:
MLT CPD code: 04201031
CME:1 point (HKCPath)  

Seminar: AcA Splice Variant of NCOR2, BQ323636.1, Activates IL-6 Signalling to Induce Resistance to Tamoxifen in Breast Cancer by : Dr Tsoi

Date: 22 Oct 2020 1:00 PM (HK)

Venue:

Venue: Conducted via Zoom
Meeting ID: 941 8792 7373

Remark:
MLT CPD code: 04201021
CME:1 point (HKCPath)

Seminar: Activity-based Protein Profiling (ABPP) for Drug Research and Development by : Dr Clive Chung

Date: 13 Aug 2020 13:00

Venue:

Conducted by Zoom 

Remark:

Click Here to join or by zoom 

Meeting ID:946 6507 3911

Application Postgraduate Diploma in Molecular and Diagnostic Pathology Deadline 12Aug 2020

Date: Application Dead line 12.8.2020 noon

Venue:

Application Deadline 1200(noon) 12 Aug 2020

Remark:

Symposium 2019/20: State Key Laboratory of Liver Research (HKU) and Theme-based Research Scheme Project on Liver Cancer Stemness

Date: Postponed until further notice

Venue:

18 July 2020(Saturday).

Due to COVID-19 situation, Symposium change to online with zoom

8th Hong Kong Pathology Forum

Date: Postponed until further notice

Remark:
For information and online registration, postponed

2019
Seminar: Roles of B Cells in Autoimmune Disease
Professor Liwei Lu
Division of Immunology, Department of Pathology, The University of Hong Kong
Date: December 12, 2019 (Thursday) 1:00 pm
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04191051
CME: 1 point (HKCPath)
Seminar: How AI Deep Learning Can Map into Digital Pathology: Basics to Research - Applications in Whole Slide Imaging
Dr Efstratios Tsougenis
Overseas Technical & Business Director, Imsight Technology Company
Date: November 28, 2019 (Thursday) 1:00 pm
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04191041
CME: 1 point (HKCPath)
The Role of Transcription Factor Activating Enhancer-binding Protein-4 (TFAP4) in the Reactivation of Telomerase Reverse Transcriptase (TERT) in Hepatocellular Carcinoma
Miss Lim Huiju
MPhil student (Supervisor: Professor Ng Oi Lin Irene)
Date: November 21, 2019 (Thursday) 1:00 pm -2:00 pm
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
CMTM4 Determines the Efficiency of PD-1/PD-L1 Blockade in Liver Cancer
Miss Chui Nog Oin Noreen
MPhil student (Supervisor: Dr Wong Chak Lui Carmen)
Date: November 21, 2019 (Thursday) 1:00 pm -2:00 pm
Venue: Room 035, 6/F, Block T
Queen Mary Hospital

Seminar: Research Postgraduate

Date: Oct 31, 2019 (Thursday) 1:00 pm -2:00 pm

Venue:
Room 035, 6/F, Block T
Queen Mary Hospital

Seminar: Research Postgraduate

Date: Oct 31, 2019 (Thursday) 1:00 pm -2:00 pm

Venue:
Room 035, 6/F, Block T
Queen Mary Hospital

Seminar: Multidimenisional Analysis of Tumour Microenvironment in Hepatocellular Carcinoma

Date: Oct 11, 2019 (Friday) 4:00 pm

Venue:
Lecture Theatre, 2/F, Block T
Queen Mary Hospital

Seminar: Research Postgraduate

Date: August 29, 2019 (Thursday) 1:00 pm -2:00 pm

Venue:
Room 035, 6/F, Block T
Queen Mary Hospital

Seminar: Research Postgraduate

Date: August 29, 2019 (Thursday) 1:00 pm -2:00 pm

Venue:
Room 035, 6/F, Block T
Queen Mary Hospital
Seminar: Novel CEST MRI Diagnostics and Theranostics for Cancer Imaging and Therapy
Dr Jeff W M Bulte
Professor of Radiology and Radiological Science, Director of Cellular Imaging, Institute for Cell Engineering, Director of Scientific Communications, Dept of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Date: August 9, 2019 (Thursday) 12:00 noon
Venue: Seminar Room 3 (G05), G/F, HKJB Building for Interdisciplinary Research, 5 Sassoon Road, Pokfulam
MLT CPD code: 04191021
CME: 1 point (HKCPath)

Seminar: Research Postgraduate

Date: August 1, 2019 (Thursday) 1:00 pm - 2:00 pm

Venue:
Room 035, 6/F, Block T, Queen Mary Hospital

Seminar: Research Postgraduate

Date: August 1, 2019 (Thursday) 1:00 pm - 2:00 pm

Venue:
Room 035, 6/F, Block T, Queen Mary Hospital

Seminar: Research Postgraduate

Date: July 4, 2019 (Thursday) 1:00 pm - 2:00 pm

Venue:
Room 035, 6/F, Block T, Queen Mary Hospital

Seminar: Research Postgraduate

Date: July 4, 2019 (Thursday) 1:00 pm - 2:00 pm

Venue:
Room 035, 6/F, Block T, Queen Mary Hospital
Seminar: Interactions of B and T cells in Protective Immunity Against Respiratory Viral Infections
Dr Wang Xiaohui
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: May 30, 2019 (Thursday) 1:00 pm
Venue: Room 035, 6/F, Block T, Queen Mary Hospital
MLT CPD code: 04191011
CME: 1 point (HKCPath)
Seminar: Targeting the BQ Variant of NCOR2 to Reverse Tamoxifen Resistance in Breast Cancer
Dr Tsoi Ho
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: April 18, 2019 (Thursday) 1:00 pm
Venue: Room 035, 6/F, Block T, Queen Mary Hospital
MLT CPD code: 04181181
CME: 1 point (HKCPath)
Seminar: Epithelial Mesenchymal Transition in Carcinoma; Therapeutic Opportunities
Professor Jean Paul Thiery
Research Director Emeritus, The Institut Gustave Roussy Comprehensive Cancer Center, The CNRS unit Matter and Complex Systems in Paris, France
Date: March 26, 2019 (Thursday) 4:00 pm
Venue: Lecture Theatre, 2/F, Block T, Queen Mary Hospital
MLT CPD code: 04181171
CME: 1 point (HKCPath)
Seminar: Liquid Biopsy and Cancer Screening – Hope or Hype?
Professor John M Nicholls
School of Biomedical Sciences, The University of Hong Kong
Date: March 21, 2019 (Thursday) 1:00 pm
Venue: Room 035, 6/F, Block T, Queen Mary Hospital
MLT CPD code: 04181131
CME: 1 point (HKCPath)
Seminar: Artificial Intelligence in Medicine: Ethical Challenges
Bernard Lo, M.D.
President & CEO, The Greenwall Foundation
Date: March 14, 2019 (Thursday) 1:00 pm
Venue: Lecture Theatre, 2/F, Block T, Queen Mary Hospital, 102 Pokulam Road, Hong Kong
MLT CPD code: 04181141
CME: 1 point (HKCPath)

Pathology 100th Anniversary & 7th Hong Kong Pathology Forum

Date: January 25-26, 2019 (Friday- Saturday)

Venue:

Lecture Theatre, 2/F, Block T, Queen Mary Hospital, 102 Pokulam Road, Hong Kong

Room N201 (New Wing), Hong Kong Convention & Exhibition Centre, Hong Kong

Remark:
For information and online registration, please click here.

2018

Symposium 2018: State Key Laboratory of Liver Research

Date: December 1, 2018 (Saturday)

Venue:
Cheung Kung Hai Lecture Theatre
4, G/F, William MW Mong Block,
21 Sassoon Road, Pokfulam
Remark:
For information and online registration, please click here.
Seminar: Kidneys and Blood Clots: Science and Machine Intelligence in Healthcare
Dr Dr. S. Joshua Swamidass
Faculty Lead, Translational Bioinformatics, Institute for Informatics Associate Professor, Laboratory and Genomic Medicine Washington University in Saint Louis
Date: 1:00 pm, Thursday, 1 November 2018
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04181101
CME: 1 point (HKCPath)
Seminar: Clinical Significance and Functional Role of Nuclear Met in Hepatocellular Carcinoma
Dr Tey Sze Keong
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 25 October 2018
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04181091
CME: 1 point (HKCPath)
Seminar: Rare, Undiagnosed Diseases and Novel Disease Mechanisms
Professor Lam Ching Wan
Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 27 September 2018
Venue: Lecture Theatre, Block T
Queen Mary Hospital
MLT CPD code: 04181081
CME: 1 point (HKCPath)
Seminar: Identification and Characterization of Pathogenic Plasma Cells in Systemic Lupus Erythematosus
Dr Ma Kongyang
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 20 September 2018
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04181071
CME: 1 point (HKCPath)
Seminar: KIF7 Attenuates Prostate Tumor Growth through LKB1-Mediated AKT Inhibition
Dr Liu Jing
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 30 August 2018
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04181061
CME: 1 point (HKCPath)
Seminar: New Therapeutics for Liver Cancer beyond Tyrosine Kinase Inhibitors: from Targeting the Cancer Cells to Awakening the Immune System
Dr Wong Chak Lui, Carmen
Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 23 August 2018
Venue: Room 035, 6/F, Block T
Queen Mary Hospital
MLT CPD code: 04181051
CME: 1 point (HKCPath)
Seminar: C-terminal Truncated Hepatitis B Virus X Protein-induced Caveolin-1 Activates Canonical Wnt Pathway in Promoting Hepatocarcinogenesis
r Mao Xiaowen
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 5 July 2018
Venue: Room 035, 6/F, Block T Queen Mary Hospital
MLT CPD code: 04181041
CME: 1 point (HKCPath)
Seminar: Characterization of the Roles of Midline-1 Interacting Protein 1, MID1IP1 in Hepatocarcinogenesis
Dr Chiu Yung Tuen, Elley
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 24 May 2018
Venue: Room 035, 6/F, Block T Queen Mary Hospital
MLT CPD code: 04181031
CME: 1 point(HKCPath)
Seminar: MicroRNA Profiling of Gastric Cancer
Dr Chan April Sheila
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 24 May 2018
Venue: Room 035, 6/F, Block T Queen Mary Hospital
MLT CPD code: 04181021
CME: 1 point(HKCPath)
Seminar: Functional Genomic and Epigenetic Landscapes of Liver Cancer
Dr Wong Chun Ming, Jack
Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 24 May 2018
Venue: Room 035, 6/F, Block T Queen Mary Hospital
MLT CPD code: 04181011
CME: 1 point(HKCPath)
Seminar: Characterization of Gene Mutations in HCC and their Functional Implications
Dr Chan Lo Kong
Research Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 29 March2018
Venue: Room 035, 6/F., Block T Queen Mary Hospital
MLT CPD code: 04171171
CME: 1 point(HKCPath) , MLT Board - 1 CPD point

6th Hong Kong Pathology Forum (2018)

Date: Date: February 3, 2018 (Saturday)

Venue:

Venue:Room N201 (New Wing), Hong Kong Convention & Exhibition Centre, Hong Kong

Seminar: The Role of Cripto-1 in Hepatocellular Carcinoma
Dr Regina Lo
Clinical Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 8 February 2018
Venue: Room 035, 6/F., Block T Queen Mary Hospital
MLT CPD code: 04171161
CME: 1 point (HKCPath) , 1 point (MLT Board)
Seminar: Understanding the Transcriptional Regulation of HBV Replication and its Implication on Hepatocarcinogenesis
Dr Sze Man Fong, Karen
Assistant Research Officer, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 1 February 2018
Venue: Room 035, 6/F., Block T Queen Mary Hospital
MLT CPD code: 04171141
CME: 1 point (HKCPath) , 1 point (MLT Board)

2017
Seminar: mTOR Inhibition Combined with Phenformin in Hepatocellular Carcinoma Management
Dr Xuemei Ge
Post-doctoral Fellow, Bellvitge Biomedical Research Institute, Barcelona, Spain
Date: 1:00 PM, Thursday, 7 December 2017
Venue: Mrs Cheng Yang Foo Oi Telemedicine Centre
2/F, Room A2-08, William MW Mong Block, FMB
MLT CPD code: 04171131
CME: 1 point (HKCPath) , 1 point (MLT Board)

Farewell UPB 21, October, 2017

Date: 21 Oct 2017

Venue:

Remark:

The University Pathology Building (UPB) will be decommissioned in 2018 as part of the Queen Mary Hospital (QMH) redevelopment plan. Since its establishment, UPB has played important role in the undergraduate and postgraduate education of pathology in Hong Kong as well as contributing to breakthrough in research and advancement of clinical services. Besides lectures and practical classes for pathology teaching for medical students, postgraduate courses for medical and related professions are also held in UPB. UPB is also the venue for the annual College examinations. In recent years, educational workshop for the public, particularly high school students, are often conducted in UPB as activities to publicize the International Pathology Day.

To cherish fond memories of UPB and to celebrate its historical importance, the University of Hong Kong Departments of Microbiology and Pathology jointly organized a “Farewell to UPB” on October 21, 2017 (Sat).

Fare UPB even photos

Seminar: Signal Cross-Talks in Leukemia, Anemia and Liver Cancer
Professor Gen-Sheng Feng
Professor of Pathology and Molecular Biology, University of California San Diego
Date: 1:00 pm, 1 December 2017
Venue: Seminar Room 4, G/F, Laboratory Block
Faculty of Medicine Building, 21 Sassoon Road
MLT CPD code: 04171121
CME: 1 point (HKCPath) , 1 point (MLT Board)
Seminar: GATA4 – a Transcription Factor Beyond a Differentiation Driver in Liver
Dr Timothy Wai Ho Shuen
Research Fellow, Laboratory of Cell Therapy and Cancer Vaccine, National Cancer Centre Singapore, Singapore
Date: 1:00 pm, Thursday, 16 November 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171111
CME: 1 point (HKCPath) , 1 point (MLT Board)

Symposium 2017: State Key Laboratory for Liver Research

Seminar: Interplay between Influenza Hemagglutinin and Neuraminidase
Dr Lai Chun Cheong Jimmy
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 9 November 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171101
CME: 1 point (HKCPath),1 point (MLT Board)
Technology Seminar: The Power of Targeted Sequencing - Enhancing Mutations Discovery
Aimee Chiu, PhD
Product Specialist, Molecular Solutions, Roche Diagnostics (Hong Kong) Ltd
Date: 10:30 Wednesday, 25 October 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
Seminar: Watching the Great Myeloid Cell Migration
Dr Lai Guan Ng
Adjunct Assistant Professor, National University of Singapore
Date: 1:00 pm, Tuesday, 24 October 2017
Venue: Lecture Theatre, 1/F
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171091
CME: 1 point (HKCPath),1 point (MLT Board)
Seminar: Immune Cell Fractions Analysis in Gastric Cancer
Dr Siu Hoi Cheong
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 12 October 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171081
CME: 1 point (HKCPath),1 point (MLT Board)
Seminar: Frequent TERT Genomic Alterations in HBV-Associated HCC and Elucidation of Novel Mechanisms
Dr Ho Wai Hung, Daniel
Research Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 21 September 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171071
CME: 1 point (HKCPath),1 point (MLT Board)
Seminar: Are We Missing Myelofibrosis? A Review of Prefibrotic MF and the WHO 2016 Criteria
Dr. Matthew Wright
Clinical Senior Lecturer, Faculty of Health and Medical Sciences, University of Western Australia
Head, Haematology Department, Fiona Stanley Hospital, Perth, Western Australia
Date: 6:00 pm, Tuesday, September 19, 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171061
CME: 1 point (HKCPath),1 point (MLT Board)
Seminar: Molecular Pathology and the Pathology Curriculum
Dr Martin Young
Consultant Histo/Cytopathologist, Royal Free London NHS Foundation Trust
Head of School of Pathology, University College London Medical School
Date: 5:00 – 6:00 PM, Tuesday, September 5, 2017
Venue: Lecture Theatre, 1/F University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171051
CME: 1 point (HKCPath),1 point (MLT Board)
Seminar: Caveolin-1, A Cancer Metastasis Promoter in Liver Cancer
Dr Judy Yam
Associate Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 31 August 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171041
CME: 1 point (HKCPath)

Croucher Symposium in Cancer Biology 2017

Seminar: Endocrine Pathology Update in 2017: Adrenocortical and Pancreatic Neuroendocrine Tumor Based upon WHO 2017
Professor Hironobu Sasano
Professor, Department of Pathology, Tohoku University School of Medicine, Japan
Director, Department of Pathology, Tohoku University Hospital
Deputy Dean, Tohoku University School of Medicine
Date: 4:00 pm, Thursday, 8 Jun 2017
Venue: Lecture Theatre, 1/F
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171031
CME: 1 point (HKCPath)
Seminar: From Dendritic Cells to Designer Vaccines?
Professor Jonathan M. Austyn
Professor of Immunology, Nuffield Department of Surgical Sciences, Fellow of the Wolfson College, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
Date: 1:00 pm, Monday, 22 May 2017
Venue: Lecture Theatre, 1/F
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171021
CME: 1 point (HKCPath)
Seminar: In Search of Molecular Targets of Ovarian Cancer
Dr Wong Gee Wan, Oscar
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 11 May 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04171011
CME: 1 point (HKCPath)
Seminar: Dishevelled-3 Phosphorylation Governed by HIPK2/PP1Cα/ITCH Axis Mediates Cancer Stemness via LGR5 in Liver Cancer
Dr Yu-Man Tsui
Post-doctoral Fellow, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 6 April 2017
Venue: G004, Conference Room,
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161241
CME: 1 point (HKCPath)
Seminar: Liver Fibrosis - Pathology and Pathogenesis
Dr Andrew Clouston
Professor, The University of Queensland, Brisbane, Australia
Date: 4:00 – 5:00 PM, Thursday, March 30, 2017
Venue: Lecture Theatre, 1/F,
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161251
CME: 1 point (HKCPath)
Seminar: Approach to Hepatocellular Nodules including Immunohistochemistry
Dr Andrew Clouston
Professor, The University of Queensland, Brisbane, Australia
Date: 5:00 – 6:00 PM, Thursday, March 30, 2017
Venue: Lecture Theatre, 1/F,
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161251
CME: 1 point (HKCPath)
Seminar: Targeting of Super-enhancer Associated Oncogenes in Hepatocellular Carcinoma
Dr Felice Tsang
Research Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 23 March 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161231
CME: 1 point (HKCPath)
Seminar: Proteomic Profiling of Gastrointestinal Cancers
Dr Helen Yan
Research Assistant Professor, Department of Pathology, The University of Hong Kong
Date: 1:00 pm, Thursday, 9 March 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161221
CME: 1 point (HKCPath)
Seminar: Stearoyl-CoA Desaturase Promotes Liver Cancer via a Positive Loop for Canonical Wnt Pathway
Dr Keane Lai
Division Chief, Chemical Pathology, Department of Pathology, Research Center for Alcoholic Liver and Pancreatic Diseases & Cirrhosis and Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, USA
Date: 1:00 PM, Thursday, 23 February 2017
Venue: G004, Conference Room
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161211
CME: 1 point (HKCPath)
Seminar: Histological aspects of cholestatic disorders
Dr Alberto Quaglia
Consultant Histopathologist, Honorary Reader in Liver Histopathology, King’s College London, Institute of Liver Studies, King’s College Hospital, London, United Kingdom
Date: 1:00 PM, Thursday, 9 February 2017
Venue: Lecture Theatre, 1/F
University Pathology Building
Queen Mary Hospital
MLT CPD code: 04161191
CME: 1 point (HKCPath)

Crocher Summer Course in Cancer Biology 2017

5th Hong Kong Pathology Forum

Date: 10 & 11 February, 2017

Venue:
Hong Kong Convention & Exhibition Centre